Review, 2010
What is the recommended way to diagnose and treat PMDD?
PMDD affects 3-5% of women and causes severe symptoms. Selective serotonin reuptake inhibitors (SSRIs, a type of antidepressant) taken during the luteal phase (the two weeks before menstruation) are considered first-line therapy.
What they did
This is a review article presenting a diagnostic algorithm and treatment approach for PMDD.
What they found
PMDD affects 3-5% of women and causes severe depression and anxiety symptoms that impair social and work functioning. The symptoms are linked to serotonin dysregulation. SSRIs taken only during the symptomatic luteal phase are first-line therapy.
What it means for you
PMDD has a clear recommended treatment pathway using antidepressants taken intermittently. This is a review, not original research.
3-5%
women with PMDD
About the study
- Original title
- [Diagnostic and therapeutic algorithm for the treatment of premenstrual dysphoric disorder]
- Authors
- Strkalj Ivezić S, Kusan Jukić M, Tikvica A et al.
- Journal
- Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti
- Year
- 2010
- Study design
- Review
- What was tested
- SSRI antidepressants (taken during luteal phase)
- Read the paper
- https://pubmed.ncbi.nlm.nih.gov/20922861/
Topics
Related studies
Systematic review, 2024
What are the best treatments for PMDD and PMS?
Review, 2024
What are the most effective treatments for PMDD?
Systematic review, 2024
Do SSRI antidepressants help treat PMS and PMDD?
Randomised trial, 2023
Does taking sertraline when PMDD symptoms start improve how well women function?
Guideline, 2023
How are GnRH agonists used to treat PMDD that doesn't respond to standard medications?
Review, 2022
What causes severe PMS and what treatments work?